Skip to content

Clinical efficacy research of elongated needle in the treatment of indigestion after stroke

Clinical efficacy research of elongated needle in the treatment of indigestion after stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013012
Enrollment
Unknown
Registered
2017-10-17
Start date
2017-03-01
Completion date
Unknown
Last updated
2017-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke dyspepsia

Interventions

Awn needle group:Elongated needle acupuncture
Filiform needle group:Filiform needle acupunture
medicine group:Oral drug treatment

Sponsors

First Hospital Affiliated to Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. the diagnostic criteria of TCM and Western medicine for the above stroke and the postprandial discomfort syndrome of dyspepsia; 2. The age ranged from 40~70 to 70 years old (including 40 years of age and one year old); 3. The course of Dyspepsia after stroke within 2-4 weeks; 4. Clear awareness, physical examination, no aphasia and severe cognitive impairment; 5. Patients and their families understand informed consent and sign it.

Exclusion criteria

Exclusion criteria: 1. Dyspeptic epigastric pain syndrome; 2. patients who had been treated with other dyspeptic symptoms within 2 weeks or were enrolled in other clinical trials; 3. The patients with severe peptic ulcer, positive fecal occult blood, severe dysplasia of gastric mucosa, or organic lesions; 4. patients with severe anxiety and depression and suicidal tendency; 5. The patients with severe heart disease, liver dysfunction (ALT AST, 1.5 times higher than the upper limit of normal) and renal insufficiency (Cr beyond the upper limit of the normal value of BUN, 1.2 times higher than the upper limit of the normal value), a serious disease of hematopoietic system and metabolic system etc.; 6. We can not cooperate with the procedure; 7. The pregnant and lactating women; 8. The allergic or allergy to drugs.

Design outcomes

Primary

MeasureTime frame
Quantization table of TCM symptom classification of dyspepsia;

Secondary

MeasureTime frame
pro-gastrin-releasing peptide;

Contacts

Public ContactHongyue Niu

First Hospital Affiliated to Tianjin University of Traditional Chinese Medicine

nhy1966@sina.com+86 13820689368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026